Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait.

Abstract excerpt

There is a group of beta (β)-thalassemia trait 'carriers' (with heterozygous mutations) who should be asymptomatic with minor abnormalities in their hematological parameters, but experience more severe disease manifestations than predicted based solely on their β-globin genotype. This review focuses on literature describing trans-acting genetic modifiers outside of the α- and β-globin gene clusters that could...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to alpha-Globins
• Share to beta-Globins
• Share to beta-Thalassemia